Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Ablexis LLC
Headquarters: San Diego, CA, United States of America
Website: http://www.ablexis.com
Year Founded: 2009
Status: Private
BioCentury | Sep 26, 2022
Management Tracks
AZ veteran Julie Brown becomes CFO at GSK
Plus AstriVax appoints chair and updates from Section 32, Janux and Alivamab
BioCentury | Mar 9, 2017
Finance
Pharmas learn their A, B, seeds
Analyzing the surge of newco formations involving corporate VCs
BioCentury | Jan 20, 2017
Company News
Ablexis, Tri-Institutional Therapeutics Discovery Institute deal
BioCentury | Aug 5, 2013
Finance
mAbs for the masses
Harbour: Small A round enough to compete with transgenic mouse platform
BioCentury | Feb 27, 2012
Emerging Company Profile
Kymab: More mAb diversity
Wellcome backing Kymab's Kymouse to create diverse human antibodies
BioCentury | Sep 5, 2011
Strategy
Back to School 2011: Innovation & collaboration
BioCentury Back to School issue: How biopharma, government, academia must partner
BioCentury | Jan 31, 2011
Strategy
Selling mouse futures
Ablexis, investors using open licensing model for quick ROI from AlivaMab mouse
Items per page:
1 - 10 of 17